New test that helps identify HCV in blood receives FDA approval

Roche, a pharmaceutical company, announced that the U.S. Food and Drug Administration approved the cobas TaqScreen MPX Test, v2.0.

Advertisement

The test can be used in the detection and identification of HIV, Hepatitis C virus and Hepatitis B virus in human blood. This is the latest version of the cobas TaqScreen MPX Test and it provides increased sensitivity. It uses real-time, multi-dye PCR technology to detect and discriminate for HIV, HCV and HBV.

The test has received the CE Mark and has been approved in Canada, Brazil, China and India.  

More articles on gastroenterology:

Hunterdon Healthcare opens reflux and motility center
Dr. Jennifer Leigh joins Gastroenterology Associates of Manatee
11 GI physicians recently in the news

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.